Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1061

2.

Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.

Serebruany VL, Malinin AI, Sane DC, Jilma B, Takserman A, Atar D, Hennekens CH.

Eur J Pharmacol. 2004 Sep 24;499(3):315-24.

PMID:
15381054
4.
5.

Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.

Serebruany VL, Malinin AI, Oshrine BR, Sane DC, Takserman A, Atar D, Hennekens CH.

Thromb Res. 2004;113(3-4):197-204.

PMID:
15140583
7.

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.

Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S.

Clin Pharmacol Ther. 2003 Mar;73(3):232-41.

PMID:
12621388
8.

The in vitro effects of niacin on platelet biomarkers in human volunteers.

Serebruany V, Malinin A, Aradi D, Kuliczkowski W, Norgard NB, Boden WE.

Thromb Haemost. 2010 Aug;104(2):311-7. doi: 10.1160/TH10-01-0015. Epub 2010 Jun 10.

PMID:
20539903
9.
10.

Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.

de la Cruz JP, Guerrero A, González-Correa JA, Márquez E, Nacle I, Sánchez de la Cuesta F.

Eur J Clin Pharmacol. 2002 Jan;57(11):775-80.

PMID:
11871383
11.

Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness.

Serebruany V, Malinin A, Ziai W, Atar D, Pokov A, Jilma B, Hanley D.

Cerebrovasc Dis. 2006;21(1-2):98-105. Epub 2005 Dec 9.

PMID:
16340184
12.

Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy.

Serebruany V, Sani Y, Eisert C, Schevchuck A, Fong A, Hanley D.

Thromb Haemost. 2011 Jan;105(1):81-7. doi: 10.1160/TH10-05-0316. Epub 2010 Oct 26.

PMID:
20978715
13.

The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.

Serebruany VL, Kogushi M, Dastros-Pitei D, Flather M, Bhatt DL.

Thromb Haemost. 2009 Jul;102(1):111-9. doi: 10.1160/TH08-12-0805.

PMID:
19572075
14.

Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.

Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W.

Thromb Haemost. 2000 Feb;83(2):316-21.

PMID:
10739392
15.

Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease.

Malinin AI, Atar D, Callahan KP, McKenzie ME, Serebruany VL.

Eur J Pharmacol. 2003 Feb 21;462(1-3):139-43.

PMID:
12591106
16.

Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).

Serebruany VL, Malinin AI, O'connor CM, Gurbel PA; Roxifiban Oral Compound Kinetics Evaluation Trial-I Platelet Substudy.

Am Heart J. 2003 Jul;146(1):91-8.

PMID:
12851613
18.

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.

Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.

Circulation. 2007 Jun 26;115(25):3156-64. Epub 2007 Jun 11.

PMID:
17562955
19.

Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.

McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM.

Platelets. 2005 Aug;16(5):269-80.

PMID:
16011977
20.

Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.

McKenzie ME, Malinin AI, Bell CR, Dzhanashvili A, Horowitz ED, Oshrine BR, Atar D, Serebruany VL.

Blood Coagul Fibrinolysis. 2003 Apr;14(3):249-53.

PMID:
12695747

Supplemental Content

Support Center